SCHEMBL14470765

SCHEMBL14470765

CC(CC(C)c1nc(COS(C)(=O)=O)co1)NC(=O)n1nnc2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ ASAH1 Q13510 2/20 0.37
▸ F12 P00748 4/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ FAAH O00519 1/20 0.34
▸ APAF1 O14727 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ MGAM O43451 5/20 0.33
▸ AMY1A P0DUB6 5/20 0.33
▸ GAA P10253 5/20 0.33
▸ SI P14410 5/20 0.33
▸ MGAM2 Q2M2H8 5/20 0.33
▸ MGLL Q99685 1/20 0.33
▸ MIF P14174 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16357075 0.88 CYP1A2 (0.39) CYP1A2CYP3A4CYP2D6ASAH1F12
SCHEMBL14470767 0.86 ASAH1 (0.41) ASAH1F12ALDH1A1KMT2AMAPT
SCHEMBL14470768 0.81 ASAH1 (0.40) ASAH1F12KMT2AMAPTTSHR
SCHEMBL8220243 0.78 ASAH1 (0.45) CYP1A2CYP3A4CYP2D6ASAH1F12
SCHEMBL20928041 0.73 ASAH1 (0.53) ASAH1F12ALDH1A1KMT2AMAPT
SCHEMBL16357074 0.73 ASAH1 (0.43) ASAH1F12ALDH1A1KMT2AMAPT
SCHEMBL14470772 0.70 ASAH1 (0.41) ASAH1F12ALDH1A1KMT2AMAPT
SCHEMBL8218828 0.69 ASAH1 (0.45) CYP1A2CYP3A4CYP2D6ASAH1F12
SCHEMBL14470770 0.69 ASAH1 (0.39) ASAH1F12KMT2AMAPTTSHR
SCHEMBL22101596 0.67 ASAH1 (0.56) ASAH1F12ALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167426-A1 Compounds for the treatment of inflammatory disorders and microbial diseases SCHERING CORPORATION 2007-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167426-A1 Compounds for the treatment of inflammatory disorders and microbial diseases MMP12, ADAMTS1, ADAM33 CYP1A2 2345/4885CYP3A4 3543/4885CYP2D6 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback